<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02636933</url>
  </required_header>
  <id_info>
    <org_study_id>9/2014</org_study_id>
    <nct_id>NCT02636933</nct_id>
  </id_info>
  <brief_title>Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters</brief_title>
  <official_title>Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters (PRE-AR) (PREMATURELY BORN CHILDREN- ASTHMA AND ALLERGIC RHINITIS )</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stefania La Grutta, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto per la Ricerca e l'Innovazione Biomedica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PRE-AR project is a longitudinal observational study. The primary objective is the&#xD;
      assessment of lung function parameters in late preterm preschool children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PRE-AR project is a longitudinal observational study. The primary objective is the&#xD;
      assessment of lung function parameters in late preterm preschool children.&#xD;
&#xD;
      Pulmonary function tests will be performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Forced oscillation technique</measure>
    <time_frame>Baseline, 24 months, and 48 months</time_frame>
    <description>Longitudinal assessment of forced oscillation technique (FOT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spirometry</measure>
    <time_frame>Baseline, 24 months, and 48 months</time_frame>
    <description>Longitudinal assessment of spirometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interrupter resistance</measure>
    <time_frame>Baseline, 24 months, and 48 months</time_frame>
    <description>Longitudinal assessment of interrupter resistance (RINT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nasal nitric oxide</measure>
    <time_frame>Baseline, 24 months, and 48 months</time_frame>
    <description>Longitudinal assessment of nasal nitric oxide (nNO)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atopy</measure>
    <time_frame>Baseline</time_frame>
    <description>Positivity to at least one aeroallergen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasal brushing</measure>
    <time_frame>Baseline</time_frame>
    <description>Assessment of alterations and inflammatory changes in the nasal mucosa</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saliva sample</measure>
    <time_frame>24 months, and 48 months</time_frame>
    <description>Phenotypic characterization through the collection of saliva samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine analysis</measure>
    <time_frame>Baseline, 24 months, and 48 months</time_frame>
    <description>Endotypic characterization through urine proteomic analysis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">152</enrollment>
  <condition>Asthma</condition>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>59 prematurely born children</arm_group_label>
    <description>Lung function assessment of 59 prematurely born children (of both sex and 3-5 years old) attending as outpatient clinic of Pediatric Allergology &amp; Pulmonology (PAP) of Respiratory Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>93 full-term born children</arm_group_label>
    <description>Lung function assessment of a Control group of full-term born children (N=93), recruited by a collaborative Pediatricians network within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lung Function Assessment</intervention_name>
    <description>Lung Function Assessment</description>
    <arm_group_label>59 prematurely born children</arm_group_label>
    <arm_group_label>93 full-term born children</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A study population of 59 prematurely born children (of both sex and 3-5 years old)&#xD;
        attending as outpatient clinic of Pediatric Allergology &amp; Pulmonology (PAP) of Respiratory&#xD;
        Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular Immunology&#xD;
        (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR).&#xD;
&#xD;
        A Control group of full-term born children (N=93), recruited by a collaborative&#xD;
        Pediatricians network within the Institute of Biomedicine and Molecular Immunology (IBIM)&#xD;
        of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy.&#xD;
&#xD;
        The subjects will be paired up according to the sex and to the age, with a ratio 1:1.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Case group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Premature birth &lt; 37 weeks&#xD;
&#xD;
          -  5 years old ≤ Age ≥ 3 years old&#xD;
&#xD;
        Control group&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Full-term birth&#xD;
&#xD;
          -  5 years old ≤ Age ≥ 3 years old&#xD;
&#xD;
        Exclusion Criteria of both groups:&#xD;
&#xD;
          -  Pulmonary bronchodysplasia (BDP)&#xD;
&#xD;
          -  Acute respiratory infection&#xD;
&#xD;
          -  Immunological and metabolic system disease&#xD;
&#xD;
          -  Malformation of upper respiratory tract&#xD;
&#xD;
          -  Topical or systemic therapies, with antibiotics, antihistaminics and corticosteroids,&#xD;
             in the previous 30 days&#xD;
&#xD;
          -  Patients with neurological pathologies&#xD;
&#xD;
          -  Patients that are not able to perform the lung function tests&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Biomedicine and Molecular Immunology, IBIM</name>
      <address>
        <city>Palermo</city>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2015</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Istituto per la Ricerca e l'Innovazione Biomedica</investigator_affiliation>
    <investigator_full_name>Stefania La Grutta, MD</investigator_full_name>
    <investigator_title>Stefania La Grutta, MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Allergic Rhinitis</keyword>
  <keyword>Children</keyword>
  <keyword>Atopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The IPD collected will be available on december 2020.&#xD;
The following participant data will be shared:&#xD;
Pulmonary function tests&#xD;
Demographic characteristics&#xD;
All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

